Chicago Equity Partners LLC bought a new position in LivaNova PLC (NASDAQ:LIVN) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 19,629 shares of the company’s stock, valued at approximately $1,569,000.
A number of other large investors have also recently added to or reduced their stakes in the stock. Cerebellum GP LLC bought a new stake in LivaNova in the fourth quarter valued at approximately $128,000. PNC Financial Services Group Inc. lifted its position in LivaNova by 9.8% in the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after purchasing an additional 153 shares during the last quarter. Pillar Pacific Capital Management LLC bought a new stake in LivaNova in the fourth quarter valued at approximately $208,000. Shelton Capital Management bought a new stake in LivaNova in the third quarter valued at approximately $209,000. Finally, Crossmark Global Holdings Inc. bought a new stake in LivaNova in the third quarter valued at approximately $263,000. Institutional investors own 88.53% of the company’s stock.
Several analysts have weighed in on LIVN shares. ValuEngine upgraded LivaNova from a “hold” rating to a “buy” rating in a research report on Thursday, November 2nd. BidaskClub downgraded LivaNova from a “buy” rating to a “hold” rating in a research report on Wednesday. Canaccord Genuity restated a “hold” rating and set a $76.00 target price on shares of LivaNova in a report on Tuesday, December 5th. Piper Jaffray Companies restated a “buy” rating and set a $85.00 target price on shares of LivaNova in a report on Friday, November 3rd. Finally, Needham & Company LLC upped their target price on LivaNova from $93.00 to $97.00 and gave the company a “buy” rating in a report on Tuesday, December 5th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company’s stock. LivaNova presently has a consensus rating of “Hold” and a consensus price target of $79.71.
LivaNova PLC (NASDAQ:LIVN) opened at $83.35 on Thursday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.42 and a current ratio of 2.03. The company has a market capitalization of $3,941.78, a P/E ratio of 23.56, a P/E/G ratio of 2.43 and a beta of 0.83. LivaNova PLC has a twelve month low of $46.34 and a twelve month high of $88.56.
TRADEMARK VIOLATION NOTICE: “Chicago Equity Partners LLC Invests $1.57 Million in LivaNova PLC (NASDAQ:LIVN)” was first posted by Week Herald and is the sole property of of Week Herald. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://weekherald.com/2018/02/15/chicago-equity-partners-llc-purchases-shares-of-19629-livanova-plc-livn.html.
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.